Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System

NCT00611585 is registered in ClinicalTrials.gov with Smith & Nephew, Inc. as lead sponsor.

NCT NCT00611585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00611585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Lead sponsor
Smith & Nephew, Inc.
Phase
Observational
Overall status
Completed
Start date
October 6, 2006
Completion date
May 12, 2025
Enrollment
329 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis